HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Elisa Rossi Selected Research

Mammaglobin B

7/2013Secretoglobin expression in ovarian carcinoma: lipophilin B gene upregulation as an independent marker of better prognosis.
7/2009Mammaglobin B is an independent prognostic marker in epithelial ovarian cancer and its expression is associated with reduced risk of disease recurrence.
6/2007Overexpression of mammaglobin B in epithelial ovarian carcinomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Elisa Rossi Research Topics

Disease

20Neoplasms (Cancer)
07/2015 - 06/2003
8Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2009 - 07/2003
7Hereditary Hemorrhagic Telangiectasia
01/2022 - 01/2012
7Carcinoma (Carcinomatosis)
07/2013 - 06/2006
4Adenocarcinoma
12/2012 - 03/2008
3Vascular Diseases (Vascular Disease)
01/2022 - 01/2018
3Hemorrhage
01/2022 - 02/2009
3Inflammation (Inflammations)
08/2021 - 01/2013
3Heart Failure
09/2020 - 06/2003
3Ovarian Neoplasms (Ovarian Cancer)
06/2007 - 11/2006
3Neoplasm Metastasis (Metastasis)
06/2007 - 11/2006
2Epistaxis (Nosebleed)
01/2022 - 01/2019
2Chronic Obstructive Pulmonary Disease (COPD)
01/2022 - 11/2020
2Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 10/2020
2Telangiectasis (Telangiectasia)
01/2019 - 01/2018
2Acute Coronary Syndrome
09/2014 - 08/2013
2Celiac Disease (Celiac Sprue)
06/2013 - 08/2011
2Ovarian Epithelial Carcinoma
07/2009 - 06/2007
2Disease Progression
08/2004 - 07/2003
1Rupture
01/2022
1Inborn Genetic Diseases (Disease, Hereditary)
01/2022
1COVID-19
01/2021
1Respiratory Insufficiency (Respiratory Failure)
01/2021
1Critical Illness (Critically Ill)
01/2021
1Aortic Valve Disease
01/2021
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2020
1Idiopathic Pulmonary Fibrosis
01/2019
1Arteriovenous Malformations (Arteriovenous Malformation)
01/2019
1Thrombasthenia (Glanzmann Thrombasthenia)
01/2018
1Ischemia
10/2017
1Hypothyroidism
08/2017
1Heart Diseases (Heart Disease)
03/2017
1Pre-Eclampsia (Preeclampsia)
04/2016
1Bronchiolitis
01/2016
1Respiratory Tract Diseases (Respiratory Tract Disease)
01/2016
1Pulmonary Hypertension
10/2015
1Hemangioma (Angioma)
07/2015
1Lung Neoplasms (Lung Cancer)
11/2014
1Sarcoma (Soft Tissue Sarcoma)
09/2013
1Follicular Dendritic Cell Sarcoma
09/2013
1Barrett Esophagus (Barrett's Esophagus)
12/2012

Drug/Important Bio-Agent (IBA)

14Proteins (Proteins, Gene)FDA Link
03/2017 - 05/2005
10EndoglinIBA
01/2022 - 01/2012
10ErbB Receptors (EGF Receptor)IBA
09/2013 - 07/2003
8Biomarkers (Surrogate Marker)IBA
01/2022 - 11/2006
6Tyrosine Kinase InhibitorsIBA
11/2014 - 08/2004
6Gefitinib (Iressa)FDA Link
04/2009 - 07/2003
4IntegrinsIBA
01/2018 - 03/2007
3Biological ProductsIBA
09/2013 - 05/2007
3Mammaglobin BIBA
07/2013 - 06/2007
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021 - 03/2007
2Oxygen (Dioxygen)IBA
11/2020 - 06/2003
2DNA (Deoxyribonucleic Acid)IBA
09/2013 - 05/2005
2ParaffinIBA
07/2013 - 06/2007
2Messenger RNA (mRNA)IBA
07/2013 - 07/2009
2UteroglobinIBA
07/2013 - 06/2007
2TransglutaminasesIBA
06/2013 - 08/2011
2ChemokinesIBA
01/2013 - 03/2007
2Epidermal Growth Factor (EGF)IBA
12/2008 - 05/2005
21-oleoyl-2-stearoylphosphatidylcholineIBA
03/2007 - 11/2006
2OligonucleotidesIBA
03/2007 - 11/2006
2Heparin (Liquaemin)FDA LinkGeneric
03/2007 - 06/2003
1Blood Coagulation Factors (Coagulation Factor)IBA
01/2022
1Estrogens (Estrogen)FDA Link
01/2022
1ProlactinIBA
01/2022
1CalponinsIBA
01/2022
1Angiopoietin-2IBA
01/2022
1Angiopoietin-1IBA
01/2022
1ThrombinFDA Link
01/2022
1Luteinizing Hormone (Lutropin)FDA LinkGeneric
01/2022
1Activin Receptors (Activin Receptor)IBA
01/2022
1Testosterone (Sustanon)FDA Link
01/2022
1Follicle Stimulating Hormone (Follitropin)FDA Link
01/2022
1GonadotropinsIBA
01/2022
1Actin Depolymerizing Factors (Cofilins)IBA
08/2021
1CreatinineIBA
10/2020
1LipidsIBA
10/2020
1Interleukin-8 (Interleukin 8)IBA
01/2019
1Thyroxine (Levothyroxine)FDA LinkGeneric
08/2017
1Edetic Acid (EDTA)FDA Link
03/2017
1MicroRNAs (MicroRNA)IBA
03/2017
1HMGB1 Protein (HMG1)IBA
03/2017
1Pharmaceutical PreparationsIBA
01/2016
1Epoprostenol (Prostacyclin)FDA LinkGeneric
10/2015
1Vasodilator Agents (Vasodilators)IBA
10/2015
1matrigelIBA
07/2015
1PAR-1-activating peptideIBA
07/2015
1AfatinibIBA
11/2014
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
09/2014
1LigandsIBA
09/2013
1Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
08/2013
1SecretoglobinsIBA
07/2013
1Mammaglobin AIBA
07/2013
1Formaldehyde (Formol)FDA Link
07/2013
1GliadinIBA
06/2013
1Peptides (Polypeptides)IBA
06/2013
1AcidsIBA
12/2012

Therapy/Procedure

7Therapeutics
01/2022 - 08/2004
1Noninvasive Ventilation
01/2021
1Artificial Heart (Artificial Hearts)
09/2020